Seventy-six percent of Phase I-IV trials require protocol amendments. Agentic AI platforms from ConcertAI, Biorce, and Rivia are changing that — cutting timelines by up to 20 months and amendments by 50%. A look at the new AI-native layer in clinical protocol design.
Dyno Therapeutics has become the first company to license AI-designed AAV capsids for both CNS and muscle gene therapies. The Astellas deal, with a $15 million upfront fee, validates that AI-designed biological sequences can pass Big Pharma's diligence process.
Space Forge generated 1,000C plasma in orbit, proving autonomous semiconductor manufacturing works. The debate: can orbital crystal growth compete with terrestrial fabs at commercial scale?
R2 Wireless raises $5.3M to expand its Odin passive RF spectrum platform as the counter-UAS market enters a structural growth phase. AI-powered passive detection is becoming the stealth layer that active radars cannot provide.
CME, ICE, and Architect Financial are racing to launch regulated futures markets for GPU compute capacity, backed by competing benchmark indices. The market follows the same arc as every commodity before it.
Palladyne AI executed a $4.2M AFRL contract to make satellites, drones and ground vehicles coordinate as one AI-driven mesh under the HANGTIME program.
Ubotica raised $11M for Live Maritime Intelligence, an orbital AI platform that detects dark vessels in real-time by processing satellite data directly in orbit. A convergence of space-based edge computing and maritime domain awareness.
Prime Intellect raised $130M Series A at $1B valuation. The open superintelligence stack lets enterprises train their own AI agents. Ramp built a model that beat Opus.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
